Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Clinical usefulness of intravenous constant rate infusion of fentanyl and medetomidine under sevoflurane anesthesia in Thoroughbred racehorses undergoing internal fixation surgery.
Journal of equine science    December 16, 2017   Volume 28, Issue 4 143-147 doi: 10.1294/jes.28.143
Mizobe F, Wakuno A, Okada J, Otsuka T, Ishikawa Y, Kurimoto S.A total of 20 racehorses with longitudinal fractures underwent internal fixation surgery under sevoflurane anesthesia combined with infusion of medetomidine (3 µg/kg/hr) alone (10 horses, group M) or medetomidine and fentanyl (7 µg/kg/hr) (10 horses, group FM). In group FM, the end-tidal sevoflurane concentration during surgery was maintained significantly lower than in group M (2.8-2.9% for group M vs. 2.2-2.6% for group FM, P<0.01). The mean arterial blood pressure was maintained over 70 mmHg using dobutamine infusion (group M, 0.36-0.54 µg/kg/min; group FM, 0.27-0.65 µg/kg/min), and ...
Plasma firocoxib concentrations after intra-articular injection of autologous conditioned serum prepared from firocoxib positive horses.
Veterinary journal (London, England : 1997)    November 20, 2017   Volume 230 20-23 doi: 10.1016/j.tvjl.2017.11.005
Ortved KF, Goodale MB, Ober C, Maylin GA, Fortier LA.Orthobiologics such as autologous conditioned serum (ACS) are often used to treat joint disease in horses. Because ACS is generated from the horse's own blood, any medication administered at the time of preparation would likely be present in stored ACS, which could lead to an inadvertent positive drug test following intra-articular (IA) injection. The main objective of this study was to determine if ACS prepared from firocoxib positive horses could result in detectable plasma concentrations of the drug following IA injection. Firocoxib was administered to six horses at 0.1mg/kg PO twice at a 2...
Descriptive study of current therapeutic practices, clinical reproductive findings and incidence of pregnancy loss in intensively managed thoroughbred mares.
Animal reproduction science    November 10, 2017   Volume 188 74-84 doi: 10.1016/j.anireprosci.2017.11.011
Rose BV, Firth M, Morris B, Roach JM, Wathes DC, Verheyen KLP, de Mestre AM.Therapeutic practices in equine reproductive medicine have dramatically evolved over the last 20 years but current usage is not described. The aims of this study were to provide a description of medication use and clinical findings of reproductive examinations alongside measures of reproductive efficiency in thoroughbreds. A prospective cohort study was conducted in the 2013 and 2014 breeding seasons. Mare and stallion details, information on veterinary interventions and findings of reproductive ultrasound scans were collected using questionnaires and entered into a custom-designed Microsoft A...
Pharmacokinetics and electrophysiological effects of sotalol hydrochloride in horses.
Equine veterinary journal    November 1, 2017   Volume 50, Issue 3 377-383 doi: 10.1111/evj.12765
Broux B, De Clercq D, Decloedt A, Vera L, Devreese M, Gehring R, Croubels S, van Loon G.Arrhythmias in horses may require long-term anti-arrhythmic therapy. Unfortunately, oral anti-arrhythmic drugs for use in horses are currently scarce. In human patients and small animals, sotalol, a β-blocker with class III anti-arrhythmic properties, is often used for long-term treatment. Objective: To determine the pharmacokinetics of sotalol at multiple oral dosages in unfasted horses, as well as the effects on electro- and echocardiographic measurements, right atrial and ventricular monophasic action potential (MAP) and effective refractory period (ERP). Methods: Placebo controlled, doubl...
Antifungal Therapy in Equine Ocular Mycotic Infections.
The Veterinary clinics of North America. Equine practice    September 27, 2017   Volume 33, Issue 3 583-605 doi: 10.1016/j.cveq.2017.08.001
Ledbetter EC.Fungi are clinically important causes of ocular infections in the horse. Keratomycosis is the most common; however, a diverse range of mycotic infections, affecting numerous ocular tissues, may be encountered. Many equine mycoses are diagnostic and therapeutic challenges. Prompt and appropriate treatment is essential to minimize morbidity and reduce the likelihood of vision loss. Knowledge of the characteristics and properties of equine ophthalmology antifungal medications is essential to selecting an optimal treatment strategy, including selection of appropriate medication and effective admin...
Quantitation of γ-aminobutyric acid in equine plasma by hydrophilic interaction liquid chromatography with tandem mass spectrometry.
Journal of separation science    July 14, 2017   Volume 40, Issue 16 3239-3247 doi: 10.1002/jssc.201700245
Yi R, Zhao S, Kong N, Zhang J, Loganathan D, Mérette S, Morrissey B.γ-Aminobutyric acid is the principal inhibitory neurotransmitter in the central nervous system and regulates the neuronal excitability. There has been anecdotal evidence that γ-aminobutyric acid has been used within a few hours prior to competition in equine sports to calm down nervous horses. However, regulating the use of γ-aminobutyric acid is challenging because it is an endogenous substance in the horse. γ-Aminobutyric acid is usually present at low ng/mL levels in equine plasma; therefore, a sensitive method has to be developed to quantify these low background levels. Measuring low c...
A physiologically based model for tramadol pharmacokinetics in horses.
Journal of theoretical biology    June 23, 2017   Volume 429 46-51 doi: 10.1016/j.jtbi.2017.06.028
This work proposes an application of a minimal complexity physiologically based pharmacokinetic model to predict tramadol concentration vs time profiles in horses. Tramadol is an opioid analgesic also used for veterinary treatments. Researchers and medical doctors can profit from the application of mathematical models as supporting tools to optimize the pharmacological treatment of animal species. The proposed model is based on physiology but adopts the minimal compartmental architecture necessary to describe the experimental data. The model features a system of ordinary differential equations...
Science-in-brief: Bisphosphonate use in the racehorse: Safe or unsafe?
Equine veterinary journal    June 13, 2017   Volume 49, Issue 4 404-407 doi: 10.1111/evj.12682
McLellan J.No abstract available
Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.
Journal of the American Veterinary Medical Association    May 17, 2017   Volume 250, Issue 11 1271-1274 doi: 10.2460/javma.250.11.1271
Ziegler A, Fogle C, Blikslager A.Nonsteroidal anti-inflammatory drugs work through inhibition of cyclooxygenase (COX) and are highly effective for the treatment of pain and inflammation in horses. There are 2 clinically relevant isoforms of COX. Cyclooxygenase-1 is constitutively expressed and is considered important for a variety of physiologic functions, including gastrointestinal homeostasis. Thus, NSAIDs that selectively inhibit COX-2 while sparing COX-1 may be associated with a lower incidence of adverse gastrointestinal effects. Various formulations of firocoxib, a COX-2-selective NSAID, labeled for use in horses are av...
Disposition of levetiracetam in healthy adult horses.
Journal of veterinary pharmacology and therapeutics    May 15, 2017   Volume 41, Issue 1 92-97 doi: 10.1111/jvp.12417
Cesar FB, Stewart AJ, Boothe DM, Ravis WR, Duran SH, Wooldridge AA.Nine horses received 20 mg/kg of intravenous (LEV ); 30 mg/kg of intragastric, crushed immediate release (LEV ); and 30 mg/kg of intragastric, crushed extended release (LEV ) levetiracetam, in a three-way randomized crossover design. Crushed tablets were dissolved in water and administered by nasogastric tube. Serum samples were collected over 48 hr, and levetiracetam concentrations were determined by immunoassay. Mean ± SD peak concentrations for LEV and LEV were 50.72 ± 10.60 and 53.58 ± 15.94 μg/ml, respectively. The y-intercept for IV administration was 64.54 ± 24.99 μg...
Alfaxalone for maintenance of anaesthesia in ponies undergoing field castration: continuous infusion compared with intravenous boluses.
Veterinary anaesthesia and analgesia    April 14, 2017   Volume 44, Issue 4 832-840 doi: 10.1016/j.vaa.2016.06.004
Deutsch J, Ekiri A, de Vries A.To compare alfaxalone as continuous intravenous (IV) infusion with intermittent IV injections for maintenance of anaesthesia in ponies undergoing castration. Methods: Prospective, randomized, 'blinded' clinical study. Methods: A group of 33 entire male Welsh ponies undergoing field castration. Methods: After preanaesthetic medication with IV detomidine (10 μg kg) and butorphanol (0.05 mg kg), anaesthesia was induced with IV diazepam (0.05 mg kg) followed by alfaxalone (1 mg kg). After random allocation, anaesthesia was maintained with either IV alfaxalone 2 mg kg hour (group A; n ...
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis.
Equine veterinary journal    April 9, 2017   Volume 49, Issue 6 710-717 doi: 10.1111/evj.12680
Calzetta L, Roncada P, di Cave D, Bonizzi L, Urbani A, Pistocchini E, Rogliani P, Matera MG.Equine asthma is a disease characterised by reversible airflow obstruction, bronchial hyper-responsiveness and airway inflammation following exposure of susceptible horses to specific airborne agents. Although clinical remission can be achieved in a low-airborne dust environment, repeated exacerbations may lead to irreversible airway remodelling. The available data on the pharmacotherapy of equine asthma result from several small studies, and no head-to-head clinical trials have been conducted among the available medications. Objective: To assess the impact of the pharmacological interventions...
Science-in-brief: Clinical highlights from 50th Congress of the South African Equine Veterinary Association 2017.
Equine veterinary journal    April 8, 2017   Volume 49, Issue 3 266-268 doi: 10.1111/evj.12678
Miller SM, Spargo KE.No abstract available
Compounding of Veterinary Drugs for Equine Practitioners.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 213-225 doi: 10.1016/j.cveq.2016.12.003
Stanley SD, Moffitt K, Wiebe V.Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
Inhalation Therapy in Horses.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 29-46 doi: 10.1016/j.cveq.2016.11.007
Cha ML, Costa LR.This article discusses the benefits and limitations of inhalation therapy in horses. Inhalation drug therapy delivers the drug directly to the airways, thereby achieving maximal drug concentrations at the target site. Inhalation therapy has the additional advantage of decreasing systemic side effects. Inhalation therapy in horses is delivered by the use of nebulizers or pressured metered dose inhalers. It also requires the use of a muzzle or nasal mask in horses. Drugs most commonly delivered through inhalation drug therapy in horses include bronchodilators, antiinflammatories, and antimicrobi...
Antiherpetic Drugs in Equine Medicine.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 99-125 doi: 10.1016/j.cveq.2016.12.002
Maxwell LK.Since vaccination may not prevent disease, antiherpetic drugs have been investigated for the therapy of several equine herpesviruses. Drug efficacy has been assessed in horses with disease, but most evidence is in vitro, in other species, or empirical. Oral valacyclovir is most often administered in the therapy of equine herpesvirus type-1 (EHV-1) to protect adult horses from equine herpesvirus myeloencephalopathy, while oral acyclovir is frequently administered for EHV-5 infection in the therapy of equine multinodular pulmonary fibrosis. Other antiherpetic drugs are promising but require furt...
Antimicrobial Pharmacology for the Neonatal Foal.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 47-65 doi: 10.1016/j.cveq.2016.12.004
Magdesian KG.Neonatal foals are at high risk of developing sepsis, which can be life-threatening. Early antimicrobial use is a critical component of the treatment of sepsis. Because the neonatal foal has unique pharmacologic physiology, antimicrobial choice and dosing are often different than in adult horses. Broad-spectrum, bactericidal, and intravenous antimicrobials should be considered first-line therapy for septic foals. A combination of aminoglycoside and beta-lactam antimicrobial or third-generation cephalosporin is an excellent empirical first choice for treating septic foals, until culture and sus...
Equine Pharmacology.
The Veterinary clinics of North America. Equine practice    March 23, 2017   Volume 33, Issue 1 xi doi: 10.1016/j.cveq.2017.01.001
Magdesian KG.No abstract available
Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foals.
Journal of veterinary pharmacology and therapeutics    March 19, 2017   Volume 40, Issue 4 406-410 doi: 10.1111/jvp.12402
Berlin S, Randow T, Scheuch E, Grube M, Venner M, Siegmund W.The long-acting azalide antibiotic gamithromycin is marketed for intramuscular treatment of bovine and swine infections. Off-label use in foals leads to severe local lesions likely caused by hyperosmolality of the injected solution. We provide evidence from a pharmacokinetic study in 10 warm-blooded healthy foals for intravenous bolus injection of gamithromycin diluted in distilled water to be a safe and well tolerated alternative. By intravenous dosing, markedly higher plasma exposure and better penetration into bronchoalveolar lavage cells but lower distribution into epithelial lining fluid ...
The effects of dose and diet on the pharmacodynamics of esomeprazole in the horse.
Equine veterinary journal    February 22, 2017   Volume 49, Issue 5 637-642 doi: 10.1111/evj.12670
Sykes BW, Underwood C, Mills PC.Esomeprazole warrants further investigation as a treatment for equine gastric ulcer syndrome. Objective: To investigate the duration of intraday acid suppression achieved with two doses of esomeprazole under two dietary conditions. Methods: A four way crossover design. Methods: Six adult Thoroughbreds instrumented with percutaneous gastrotomy tubes were used. Intragastric pH was measured for continuous 23 h periods (08.00-07.00 h) for 6 consecutive days (Days 0-5). Baseline data was recorded on Day 0 and esomeprazole was administered on Days 1-5. Two doses (0.5 and 2.0 mg/kg bwt/day per os onc...
Nonsteroidal Anti-inflammatory Drug Use in Horses.
The Veterinary clinics of North America. Equine practice    February 9, 2017   Volume 33, Issue 1 1-15 doi: 10.1016/j.cveq.2016.11.001
Knych HK.Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic agents and are arguably the most commonly used class of drugs in equine medicine. This article provides a brief review of the mechanism of action, therapeutic uses, pharmacokinetics, and adverse effects associated with their use in horses. The use of COX-2 selective NSAIDs in veterinary medicine has increased over the past several years and special emphasis is given to the use of these drugs in horses. A brief discussion of the use of NSAIDs in performance horses is also included.
Detection and pharmacokinetics of salmeterol in thoroughbred horses following inhaled administration.
Journal of veterinary pharmacology and therapeutics    January 17, 2017   Volume 40, Issue 5 486-492 doi: 10.1111/jvp.12382
Fenwick SJ, Hincks PR, Scarth JP, Wieder ME, Hillyer LL, Paine SW.Salmeterol is a man-made beta-2-adrenergic receptor agonist used to relieve bronchospasm associated with inflammatory airway disease in horses. Whilst judicious use is appropriate in horses in training, they cannot race with clinically effective concentrations of medications under the British Horseracing Authority's Rules of Racing. Salmeterol must therefore be withdrawn prior to race day and pharmacokinetic (PK) studies used to establish formal detection time advice. Salmeterol xinafoate (Serevent Evohaler ) was administered (0.1 mg twice daily for 4.5 days) via inhalation to six horses. Ur...
Pharmacokinetics of oral terbinafine in adult horses.
Journal of veterinary pharmacology and therapeutics    November 24, 2016   Volume 40, Issue 4 342-347 doi: 10.1111/jvp.12367
Younkin TJ, Davis EG, Kukanich B.The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o. terbinafine administered with p.o. cimetidine in healthy adult horses. The second objective was to assess the pharmacokinetics of terbinafine when administered per rectum in two different suspensions at 30 mg/kg to adult horses. Six healthy adult horses were included in this crossover study. Plasma terbinafine concentrations were quantified with liquid chromatography and mass spectrometry. The half-life (geometric mean) was 8.38 and 10.76 h, for p.o. alone and p.o. with cimetidine, respectively....
Evaluation of xylazine and ketamine for maintenance of anesthesia in horses.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 105 doi: 10.1016/S1467-2987(16)31355-1
Mama KR, Wagner AE, Steffey EP, Kollias-Baker C, Hellyer PW, Golden AE, Brevard LF.Eight horses [5.6 ± 3.6 years, 489 ± 48.6 kg (mean ± SD)] were anesthetized four times under laboratory conditions to characterize physiologic and behavioral (reported elsewhere) responses associated with a 1-hours period of total intravenous anesthesia (TIA). Each horse was premedicated with xylazine (X, 0.75 mg kg−1) and anesthesia induced 5 minutes later with 5% guaifenesin (75 mg kg−1) and ketamine (K, 2 mg kg−1), all given IV After anesthetic induction, horses were intubated and received one of six treatments [X 35, K 90, O2; X 35, K 120, O2; X 35, K 120, air; X 35, K150, O2; X 7...
Comparative evaluation of the analgesic effects of epidural morphine, alfentanil, butorphanol, tramadol and U50488H in horses.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 109 doi: 10.1016/S1467-2987(16)31364-2
Natalini CC, Robinson EP.No abstract available
Repeated injectable anesthesia in six horses for cobalt therapy.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 106 doi: 10.1016/S1467-2987(16)31356-3
Matthews NS, Carroll GL, Hartsfield SM, Martinez EA.No abstract available
Pharmacokinetics and toxicity of intravenously administered lithium chloride in horses.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 108 doi: 10.1016/S1467-2987(16)31361-7
Hatfield C, McDonell W, Black W.No abstract available
Epidural administration of tiletamine-zolazepam in horses.
Veterinary anaesthesia and analgesia    November 15, 2016   Volume 29, Issue 2 109 doi: 10.1046/j.1467-2995.2002.00078_29.x
Natalini CC, Alves S, Robinson EP.No abstract available
Degradation, intra-articular retention and biocompatibility of monospheres composed of [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers.
Acta biomaterialia    November 2, 2016   Volume 48 401-414 doi: 10.1016/j.actbio.2016.11.003
Sandker MJ, Duque LF, Redout EM, Chan A, Que I, Löwik CWGM, Klijnstra EC, Kops N, Steendam R, van Weeren R, Hennink WE, Weinans H.In this study, we investigated the use of microspheres with a narrow particle size distribution ('monospheres') composed of biodegradable poly(DL-lactide)-PEG-poly(DL-lactide)-b-poly(L-lactide) multiblock copolymers that are potentially suitable for local sustained drug release in articular joints. Monospheres with sizes of 5, 15 and 30μm and a narrow particle size distribution were prepared by a micro-sieve membrane emulsification process. During in vitro degradation, less crystallinity, higher swelling and accelerated mass loss during was observed with increasing the PEG content of the poly...
Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
Veterinary ophthalmology    October 28, 2016   Volume 20, Issue 5 398-404 doi: 10.1111/vop.12439
Tofflemire K, Whitley EM, Allbaugh R, Ben-Shlomo G, Griggs A, Strong T, Whitley RD.To evaluate the effect of topical ophthalmic 0.005% latanoprost alone and in combination with 0.1% diclofenac on healthy horses. Methods: Twelve healthy adult horses. Methods: A randomized, masked crossover design was used with horses divided into three groups for once daily treatment in one randomly selected eye. For arm 1 of the study, Group D (n = 3) received 0.1% diclofenac, Group L (n = 3) received 0.005% latanoprost, and Group DL (n = 6) received 0.005% latanoprost and 0.2 ml of 0.1% diclofenac. For arm 2 of the study, horses from Group D and L were placed into Group DL and horses from G...
1 5 6 7 8 9 39